EU approved two doses: 150mg bid for almost all, then 110mg bid for >80 years old, for patients at increased risk of bleeding and for patients who are co-administered with dabigatran etexilate and the calcium channel blocker verapamil.
US approved two doses: 150mg bid for almost all, then 75mg bid for renal impaired.
Market Data 
Markets 
AI
